277 filings
Page 5 of 14
8-K
vg52g5zuiz
27 Sep 22
Regulation FD Disclosure
8:36am
8-K
a11vu7b
9 Sep 22
Regulation FD Disclosure
4:00pm
8-K
onut072n9
6 Sep 22
Moleculin Receives FDA Orphan Drug Designation of WP1122 for the Treatment of Glioblastoma Multiforme
8:45am
8-K
kzw5i memt
19 Aug 22
Moleculin Announces Completion of Third Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:40am
8-K
6xooko26rak cczk2ui1
18 Aug 22
Regulation FD Disclosure
5:06pm
8-K
imcfzr05
15 Aug 22
Moleculin Reports Second Quarter 2022 Financial Results and Provides Programs Update
8:48am
8-K
2keafijoplr
28 Jul 22
Regulation FD Disclosure
8:35am
8-K
e00eb9re rad2hbnsw
8 Jul 22
Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:37am
8-K
8t1aj41b4p
16 Jun 22
Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:35am
8-K
mwfkac49d124pg651427
9 Jun 22
Regulation FD Disclosure
4:31pm
8-K
5p3wit2aqu32cdxm
31 May 22
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
pyvmbdn5b 51hl
26 May 22
Moleculin Commences Dosing in Healthy Volunteers in Phase 1a Clinical Trial of WP1122 for the Treatment of COVID-19
8:35am
8-K
u8qm1q
20 May 22
Regulation FD Disclosure
4:35pm
8-K
tvv3 f2dei6o8
12 May 22
Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update
8:35am
8-K
xnlc5p b5
10 May 22
Regulation FD Disclosure
8:35am
8-K
3mnesq tepx28urnc
5 May 22
Regulation FD Disclosure
8:15am
8-K
yyoigv5ufty3rl itug
4 May 22
Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer
8:15am
8-K
4o9rv
21 Apr 22
Moleculin Receives IND Clearance to Conduct Phase 1 Study of WP1066 for the Treatment of Recurrent Malignant Glioma
8:45am
8-K/A
pi48 1r6302r6
12 Apr 22
Moleculin Announces Presentation of Positive Preclinical Annamycin Data at the AACR 2022 Annual Meeting
8:57am
8-K
714n8ezl1
8 Apr 22
Moleculin Announces Presentation of Positive Preclinical Annamycin Data at the AACR 2022 Annual Meeting
4:32pm